SavedAdd your journal

Journals / Düzce Üniversitesi Bilim ve Teknoloji Dergisi / 2019 / Cilt: 7 - Sayı: 3

A Novel Score Fusion Approach for Breast Cancer Diagnosis

Meme Kanseri Teşhisi İçin Yeni Bir Skor Füzyon Yaklaşımı

Can EYÜPOĞLU
Erdem YAVUZ
Pages
1045–1060
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The experimental results show that the proposed method is promising for the diagnosis of breast cancer and may be used as an assisting tool in the decision-making of medical professionals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Early diagnosis of breast cancer disease is critical for patients to recover from this disease entirely as it is a common disease all over the world.
📊
Key Findings & Data:The utilities of these basic neural networks and the proposed method are examined and comparative performance results are presented.
💡
Conclusion & Impact:The experimental results show that the proposed method is promising for the diagnosis of breast cancer and may be used as an assisting tool in the decision-making of medical professionals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Skor Füzyon · Meme Kanseri Teşhisi · Sinir Ağı

Abstract

Early diagnosis of breast cancer disease is critical for patients to recover from this disease entirely as it is a common disease all over the world. In order to facilitate the diagnosis of the disease, medical doctors can benefit from computer-aided expert systems. In this paper, a score fusion method based on generalized regression neural network (GRNN) and feed forward neural network (FFNN) has been proposed so as to split breast cancer data samples into benign or malignant classes. The proposed method is tested on the Wisconsin Diagnostic Breast Cancer (WDBC) dataset. The utilities of these basic neural networks and the proposed method are examined and comparative performance results are presented. The experimental results show that the proposed method is promising for the diagnosis of breast cancer and may be used as an assisting tool in the decision-making of medical professionals.

Özet

Meme kanseri tüm dünyada yaygın bir hastalık olması sebebiyle hastalığın erken teşhisi, hastaların bu hastalıktan tamamen kurtulabilmeleri açısından kritik öneme sahiptir. Hastalığın teşhisini kolaylaştırmak için tıp doktorları bilgisayar destekli uzman sistemlerden yararlanabilmektedir. Bu çalışmada meme kanseri veri örneklerini iyi huylu veya kötü huylu sınıflarına ayırmak için genel regresyon sinir ağı (Generalized Regression Neural Network-GRNN) ve ileri beslemeli sinir ağı (Feed Forward Neural Network-FFNN) temelli bir skor füzyon yöntemi önerilmiştir. Önerilen yöntem Wisconsin Teşhis Meme Kanseri (Wisconsin Diagnostic Breast Cancer-WDBC) veri seti üzerinde test edilmiştir. Bu iki temel ağın ve önerilen yöntemin kullanışlılığı incelenmiş ve performans sonuçları karşılaştırmalı olarak sunulmuştur. Önerilen yöntem sınıflandırma doğruluğu bakımından literatürde WDBC veri setini kullanarak yapılan mevcut çalışmalar ile kıyaslanmıştır. Elde edilen deneysel sonuçlar önerilen yöntemin, meme kanseri teşhisi için umut vadettiğini ve tıp uzmanlarının hastalığa ilişkin karar vermelerinde yardımcı bir araç olarak kullanılabileceğini göstermektedir.

🔖

Cite This Article

EYÜPOĞLU, C., YAVUZ, E. (2022). A Novel Score Fusion Approach for Breast Cancer Diagnosis. Düzce Üniversitesi Bilim ve Teknoloji Dergisi, Cilt: 7 - Sayı: 3, 1045–1060. https://ajindex.com/articles/494416

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ł. Jeleń, A. Krzyżak, T. Fevens and M. Jeleń, “Influence of feature set reduction on breast cancer malignancy classification of fine needle aspiration biopsies,” Computers in Biology and Medicine, vol. 79, pp. 80-91, 2016. [2] S. Mittal, H. Kaur, N. Gautam and A.K. Mantha, “Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies,” Biosensors and Bioelectronics, vol. 88, pp. 217-231, 2017. [3] C. DeSantis, J. Ma, L. Bryan and A. Jemal, “Breast cancer statistics, 2013,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 52-62, 2014. [4] D.E. Misek and E.H. Kim, “Protein Biomarkers for the Early Detection of Breast Cancer,” International Journal of Proteomics, vol. 2011, pp. 1-9, 2011. [5] Y. Tang, Y. Wang, M.F. Kiani and B. Wang, “Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer,” Clinical Breast Cancer, vol. 16, no. 5, pp. 335-343, 2016. [6] M. Nilashi, O. Ibrahim, H. Ahmadi and L. Shahmoradi, “A knowledge-based system for breast cancer classification using fuzzy logic method,” Telematics and Informatics, vol. 34, no. 4, pp. 133-144, 2017. [7] L.E.M. Duijm, J.H. Groenewoud, F.H. Jansen, J. Fracheboud, M. van Beek and H.J. de Koning, “Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening,” British Journal of Cancer, vol. 91, no. 10, pp. 1795-1799, 2004. [8] A.M. Abdel-Zaher and A.M. Eldeib, “Breast cancer classification using deep belief networks,” Expert Systems With Applications, vol. 46, pp. 139-144, 2016. [9] G.I. Salama, M.B. Abdelhalim and M.A. Zeid, “Breast Cancer diagnosis on three different datasets using multi-classifiers,” International Journal of Computer and Information Technology, vol. 1, pp. 36-43, 2012. [10] Breast cancer society of Canada incidence statistics for 2015, (13 Aralık 2017). [Online]. Erişim: http://www.cbcf.org/central/AboutBreastCancerMain/FactsStats/Pages/Breast-Cancer-Canada. aspx [11] C. Eyupoglu, “Breast cancer classification using k-nearest neighbors algorithm,” The Online Journal of Science and Technology, vol. 8, no. 3, pp. 29-34, 2018. [12] M.H.C. Law, M.A.T. Figueiredo and A.K. Jain, “Simultaneous feature selection and clustering using mixture models,” IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 26, no. 9, pp. 1154-1166, 2004. [13] P. Luukka and T. Leppälampi, “Similarity classifier with generalized mean applied to medical data,” Com